1351775-03-5

Usage

Uses

Used in Medicinal Chemistry:
Used in Drug Development:
This complex organic compound is utilized in drug development to explore its potential as a lead molecule for the creation of novel pharmaceuticals, given its unique structure and functional groups that may interact with biological targets.
Used in Research Applications:

Downstream Products

• 1351775-04-6 (2S,20S,21S,22R,23R,24R,25S,26R,27S)-6,21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-11-methylene-1,5,15-trioxo-1,2,5,11-tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino)furo[2'',3'':7',8']naphtho[1',2':4,5]imidazo[1,2-a]pyridin-25-yl acetate 

Relevant academic research and scientific papers

Structure elucidation of two unknown oxydic degradation impurities of rifaximin

Rifaximin is a semi-synthetic rifamycin derivate. Two unknown oxydic degradation impurities (impurity 1 and impurity 2) were prepared from rifaximin based on the degradation mechanism by using manganese dioxide as the oxidant. The structure of the impurities was elucidated by using MS and other modern spectroscopic (NMR and FTIR) techniques and as (2S,20S,21S,22R,23R,24R,25S,26R, 27S)- 6,21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-11-methylene- 1,5,15-trioxo-1,2,5,11-tetrahydro-2,7- (epoxypentadeca[1,11,13]trienoimino) furo[2″,3″:7′,8′]naphtho[1′,2′:4,5] imidazo[1,2-a]pyridin-25-yl-acetate and (2S,20S,21S, 22R,23R,24R,25S,26R,27S)-5, 21,23-trihydroxy-27-methoxy-2,4,16,20,22,24,26-heptamethyl-11-methylene-1,6, 15-trioxo-1,2,6,11- tetrahydro-2,7-(epoxypentadeca[1,11,13]trienoimino) furo[2″,3″:7′,8′]naphtho[1′,2′:4,5] imidazo[1,2-a]pyridin-25-yl-acetate by IUPAC.